UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Agalsidase alfa prevents the decline in renal function in patients with Fabry disease.

Schwarting, A and Dehout, F and Feriozzi, S and Beck, M and Mehta, A and Widmer, U and Sunder-Plassmann, G (2005) Agalsidase alfa prevents the decline in renal function in patients with Fabry disease. Nephrology Dialysis Transplantation , 20 V248 - ?.

Full text not available from this repository.


Type:Article
Title:Agalsidase alfa prevents the decline in renal function in patients with Fabry disease.
UCL classification:UCL > School of Life and Medical Sciences > Faculty of Medical Sciences > Wolfson Institute and Cancer Institute Administration > Cancer Institute > Research Department of Haematology

Archive Staff Only: edit this record